351 related articles for article (PubMed ID: 10897066)
1. Treatment with meliacine, a plant derived antiviral, prevents the development of herpetic stromal keratitis in mice.
Alché LE; Berra A; Veloso MJ; Coto CE
J Med Virol; 2000 Aug; 61(4):474-80. PubMed ID: 10897066
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic action of meliacine, a plant-derived antiviral, on HSV-induced ocular disease in mice.
Pifarré MP; Berra A; Coto CE; Alché LE
Exp Eye Res; 2002 Sep; 75(3):327-34. PubMed ID: 12384095
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic effect of meliacine, an antiviral derived from Melia azedarach L., in mice genital herpetic infection.
Petrera E; Coto CE
Phytother Res; 2009 Dec; 23(12):1771-7. PubMed ID: 19441066
[TBL] [Abstract][Full Text] [Related]
4. Macrophage-depletion influences the course of murine HSV-1 keratitis.
Bauer D; Mrzyk S; van Rooijen N; Steuhl KP; Heiligenhaus A
Curr Eye Res; 2000 Jan; 20(1):45-53. PubMed ID: 10611714
[TBL] [Abstract][Full Text] [Related]
5. Role of macrophages in restricting herpes simplex virus type 1 growth after ocular infection.
Cheng H; Tumpey TM; Staats HF; van Rooijen N; Oakes JE; Lausch RN
Invest Ophthalmol Vis Sci; 2000 May; 41(6):1402-9. PubMed ID: 10798656
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic efficacy of DNA encoding IFN-alpha1 against corneal HSV-1 infection.
Noisakran SJ; Carr DJ
Curr Eye Res; 2000 May; 20(5):405-12. PubMed ID: 10855035
[TBL] [Abstract][Full Text] [Related]
7. Critical role of corneal Langerhans cells in the CD4- but not CD8-mediated immunopathology in herpes simplex virus-1-infected mouse corneas.
Hendricks RL; Janowicz M; Tumpey TM
J Immunol; 1992 Apr; 148(8):2522-9. PubMed ID: 1313845
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-10 treatment can suppress stromal keratitis induced by herpes simplex virus type 1.
Tumpey TM; Elner VM; Chen SH; Oakes JE; Lausch RN
J Immunol; 1994 Sep; 153(5):2258-65. PubMed ID: 8051423
[TBL] [Abstract][Full Text] [Related]
9. Expression of herpes virus entry mediator (HVEM) in the cornea and trigeminal ganglia of normal and HSV-1 infected mice.
Kovacs SK; Tiwari V; Prandovszky E; Dosa S; Bacsa S; Valyi-Nagy K; Shukla D; Valyi-Nagy T
Curr Eye Res; 2009 Oct; 34(10):896-904. PubMed ID: 19895317
[TBL] [Abstract][Full Text] [Related]
10. Moderation of herpetic stromal keratitis by basic fibroblast growth factor.
Gamus D; Romano A; Rubinstein M; Savion N
Exp Eye Res; 1996 Jul; 63(1):1-8. PubMed ID: 8983954
[TBL] [Abstract][Full Text] [Related]
11. Passive transfer of anti-herpes simplex virus type 2 monoclonal and polyclonal antibodies protect against herpes simplex virus type 1-induced but not herpes simplex virus type 2-induced stromal keratitis.
Ritchie MH; Oakes JE; Lausch RN
Invest Ophthalmol Vis Sci; 1993 Jul; 34(8):2460-8. PubMed ID: 8392037
[TBL] [Abstract][Full Text] [Related]
12. Effect of aminoguanidine, a nitric oxide synthase inhibitor, on ocular infection with herpes simplex virus in Balb/c mice.
Benencia F; Courrèges MC; Gamba G; Cavalieri H; Massouh EJ
Invest Ophthalmol Vis Sci; 2001 May; 42(6):1277-84. PubMed ID: 11328740
[TBL] [Abstract][Full Text] [Related]
13. A-5021: a new acyclovir analogue inhibits murine herpetic keratitis.
Itahashi M; Higaki S; Sugahara D; Sugioka K; Deai T; Takao K; Hayashi K; Shimomura Y
Cornea; 2008 Apr; 27(3):334-8. PubMed ID: 18362663
[TBL] [Abstract][Full Text] [Related]
14. Preventive effect of local plasmid DNA vaccine encoding gD or gD-IL-2 on herpetic keratitis.
Inoue T; Inoue Y; Nakamura T; Yoshida A; Takahashi K; Inoue Y; Shimomura Y; Tano Y; Fujisawa Y; Aono A; Hayashi K
Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4209-15. PubMed ID: 11095617
[TBL] [Abstract][Full Text] [Related]
15. Effects of CXCR3 signaling on development of fatal encephalitis and corneal and periocular skin disease in HSV-infected mice are mouse-strain dependent.
Lundberg P; Openshaw H; Wang M; Yang HJ; Cantin E
Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4162-70. PubMed ID: 17724202
[TBL] [Abstract][Full Text] [Related]
16. A comparison of recurrent and primary herpes simplex keratitis in NIH inbred mice.
Miller JK; Laycock KA; Umphress JA; Hook KK; Stuart PM; Pepose JS
Cornea; 1996 Sep; 15(5):497-504. PubMed ID: 8862927
[TBL] [Abstract][Full Text] [Related]
17. Effect of Fas and Fas ligand deficiency in resistance of C57BL/6 mice to HSV-1 keratitis and chorioretinitis.
Nguyen QD; Uy HS; Merchant A; Medina CA; Baltatzis S; Zhao T; Zhao ZS; Cantor H; Foster CS
Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2505-9. PubMed ID: 11581190
[TBL] [Abstract][Full Text] [Related]
18. An antiviral principle present in a purified fraction from Melia azedarach L. leaf aqueous extract restrains herpes simplex virus type 1 propagation.
Alché LE; Barquero AA; Sanjuan NA; Coto CE
Phytother Res; 2002 Jun; 16(4):348-52. PubMed ID: 12112291
[TBL] [Abstract][Full Text] [Related]
19. The role of interleukin (IL)-2 and IL-4 in herpes simplex virus type 1 ocular replication and eye disease.
Ghiasi H; Cai S; Slanina SM; Perng GC; Nesburn AB; Wechsler SL
J Infect Dis; 1999 May; 179(5):1086-93. PubMed ID: 10191208
[TBL] [Abstract][Full Text] [Related]
20. PCR assessment of HSV-1 corneal infection in animals treated with rose bengal and lissamine green B.
Stroop WG; Chen TM; Chodosh J; Kienzle TE; Stroop JL; Ling JY; Miles DA
Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2096-102. PubMed ID: 10892849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
